APO Research
Talk to an analyst

APO RESEARCH · REPORT

EGFR-TKI

Compare research editions
View pricing & licenses

Selected research

Industry Research

EGFR-TKI Industry Research Report 2026

27 December 2025133 pages

Choose your research edition.

Industry ResearchEGFR-TKI Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal EGFR-TKI Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal EGFR-TKI Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EGFR-TKI Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal EGFR-TKI Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global EGFR-TKI market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for EGFR-TKI is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for EGFR-TKI is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for EGFR-TKI is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of EGFR-TKI include ArriVent Biopharma, AstraZeneca, Beacon Pharma, Boehringer Ingelheim Pharmaceuticals, Cipla, Drug International, Glenmark Pharmaceuticals, Hanmi Pharmaceutical and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global EGFR-TKI market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

EGFR-TKI Market by Company

ArriVent Biopharma

AstraZeneca

Beacon Pharma

Boehringer Ingelheim Pharmaceuticals

Cipla

Drug International

Glenmark Pharmaceuticals

Hanmi Pharmaceutical

Johnson & Johnson

Mylan

Pfizer

Roche

Teva

Yuhan Corporation

Betta Pharma

Chengdu Brilliant Pharmaceuticals

Hansoh Pharma

Shanghai Allist Pharmaceuticals

Wanbang Biopharmaceuticals

EGFR-TKI Segment by Type

Afatinib

Aumolertinib

Icotinib

Osimertinib

Dacomitinib

Erlotinib

Furmonertinib

Gefitinib

Lazertinib

Other

EGFR-TKI Segment by Application

Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

EGFR-TKI Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EGFR-TKI market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EGFR-TKI and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EGFR-TKI.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of EGFR-TKI manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of EGFR-TKI by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of EGFR-TKI in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global EGFR-TKI Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global EGFR-TKI Sales (K Units) of Manufacturers (2021-2026) Table 7. Global EGFR-TKI Sales Market Share by Manufacturers (2021-2026) Table 8. Global EGFR-TKI Revenue of Manufacturers (2021-2026) Table 9. Global EGFR-TKI Revenue Share by Manufacturers (2021-2026) Table 10. Global Market EGFR-TKI Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global EGFR-TKI Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of EGFR-TKI, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of EGFR-TKI, Product Type & Application Table 14. Global EGFR-TKI Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global EGFR-TKI by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. ArriVent Biopharma Company Information Table 19. ArriVent Biopharma Business Overview Table 20. ArriVent Biopharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. ArriVent Biopharma EGFR-TKI Product Portfolio Table 22. ArriVent Biopharma Recent Developments Table 23. AstraZeneca Company Information Table 24. AstraZeneca Business Overview Table 25. AstraZeneca EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. AstraZeneca EGFR-TKI Product Portfolio Table 27. AstraZeneca Recent Developments Table 28. Beacon Pharma Company Information Table 29. Beacon Pharma Business Overview Table 30. Beacon Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Beacon Pharma EGFR-TKI Product Portfolio Table 32. Beacon Pharma Recent Developments Table 33. Boehringer Ingelheim Pharmaceuticals Company Information Table 34. Boehringer Ingelheim Pharmaceuticals Business Overview Table 35. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolio Table 37. Boehringer Ingelheim Pharmaceuticals Recent Developments Table 38. Cipla Company Information Table 39. Cipla Business Overview Table 40. Cipla EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Cipla EGFR-TKI Product Portfolio Table 42. Cipla Recent Developments Table 43. Drug International Company Information Table 44. Drug International Business Overview Table 45. Drug International EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Drug International EGFR-TKI Product Portfolio Table 47. Drug International Recent Developments Table 48. Glenmark Pharmaceuticals Company Information Table 49. Glenmark Pharmaceuticals Business Overview Table 50. Glenmark Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Glenmark Pharmaceuticals EGFR-TKI Product Portfolio Table 52. Glenmark Pharmaceuticals Recent Developments Table 53. Hanmi Pharmaceutical Company Information Table 54. Hanmi Pharmaceutical Business Overview Table 55. Hanmi Pharmaceutical EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Hanmi Pharmaceutical EGFR-TKI Product Portfolio Table 57. Hanmi Pharmaceutical Recent Developments Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Johnson & Johnson EGFR-TKI Product Portfolio Table 62. Johnson & Johnson Recent Developments Table 63. Mylan Company Information Table 64. Mylan Business Overview Table 65. Mylan EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Mylan EGFR-TKI Product Portfolio Table 67. Mylan Recent Developments Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Pfizer EGFR-TKI Product Portfolio Table 72. Pfizer Recent Developments Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Roche EGFR-TKI Product Portfolio Table 77. Roche Recent Developments Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Teva EGFR-TKI Product Portfolio Table 82. Teva Recent Developments Table 83. Yuhan Corporation Company Information Table 84. Yuhan Corporation Business Overview Table 85. Yuhan Corporation EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Yuhan Corporation EGFR-TKI Product Portfolio Table 87. Yuhan Corporation Recent Developments Table 88. Betta Pharma Company Information Table 89. Betta Pharma Business Overview Table 90. Betta Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Betta Pharma EGFR-TKI Product Portfolio Table 92. Betta Pharma Recent Developments Table 93. Chengdu Brilliant Pharmaceuticals Company Information Table 94. Chengdu Brilliant Pharmaceuticals Business Overview Table 95. Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolio Table 97. Chengdu Brilliant Pharmaceuticals Recent Developments Table 98. Hansoh Pharma Company Information Table 99. Hansoh Pharma Business Overview Table 100. Hansoh Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hansoh Pharma EGFR-TKI Product Portfolio Table 102. Hansoh Pharma Recent Developments Table 103. Shanghai Allist Pharmaceuticals Company Information Table 104. Shanghai Allist Pharmaceuticals Business Overview Table 105. Shanghai Allist Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolio Table 107. Shanghai Allist Pharmaceuticals Recent Developments Table 108. Wanbang Biopharmaceuticals Company Information Table 109. Wanbang Biopharmaceuticals Business Overview Table 110. Wanbang Biopharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Wanbang Biopharmaceuticals EGFR-TKI Product Portfolio Table 112. Wanbang Biopharmaceuticals Recent Developments Table 113. Global EGFR-TKI Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global EGFR-TKI Sales by Region (2021-2026) & (K Units) Table 115. Global EGFR-TKI Sales Market Share by Region (2021-2026) Table 116. Global EGFR-TKI Sales by Region (2027-2032) & (K Units) Table 117. Global EGFR-TKI Sales Market Share by Region (2027-2032) Table 118. Global EGFR-TKI Revenue by Region (2021-2026) & (US$ Million) Table 119. Global EGFR-TKI Revenue Market Share by Region (2021-2026) Table 120. Global EGFR-TKI Revenue by Region (2027-2032) & (US$ Million) Table 121. Global EGFR-TKI Revenue Market Share by Region (2027-2032) Table 122. North America EGFR-TKI Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 124. North America EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 125. North America EGFR-TKI Revenue by Country (2021-2026) & (US$ Million) Table 126. North America EGFR-TKI Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe EGFR-TKI Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 129. Europe EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 130. Europe EGFR-TKI Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe EGFR-TKI Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific EGFR-TKI Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific EGFR-TKI Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific EGFR-TKI Revenue by Country (2027-2032) & (US$ Million) Table 137. South America EGFR-TKI Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 139. South America EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 140. South America EGFR-TKI Revenue by Country (2021-2026) & (US$ Million) Table 141. South America EGFR-TKI Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa EGFR-TKI Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa EGFR-TKI Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa EGFR-TKI Revenue by Country (2027-2032) & (US$ Million) Table 147. Global EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 148. Global EGFR-TKI Sales by Type (2027-2032) & (K Units) Table 149. Global EGFR-TKI Sales Market Share by Type (2021-2026) Table 150. Global EGFR-TKI Sales Market Share by Type (2027-2032) Table 151. Global EGFR-TKI Revenue by Type (2021-2026) & (US$ Million) Table 152. Global EGFR-TKI Revenue by Type (2027-2032) & (US$ Million) Table 153. Global EGFR-TKI Revenue Market Share by Type (2021-2026) Table 154. Global EGFR-TKI Revenue Market Share by Type (2027-2032) Table 155. Global EGFR-TKI Price by Type (2021-2026) & (US$/Unit) Table 156. Global EGFR-TKI Price by Type (2027-2032) & (US$/Unit) Table 157. Global EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 158. Global EGFR-TKI Sales by Application (2027-2032) & (K Units) Table 159. Global EGFR-TKI Sales Market Share by Application (2021-2026) Table 160. Global EGFR-TKI Sales Market Share by Application (2027-2032) Table 161. Global EGFR-TKI Revenue by Application (2021-2026) & (US$ Million) Table 162. Global EGFR-TKI Revenue by Application (2027-2032) & (US$ Million) Table 163. Global EGFR-TKI Revenue Market Share by Application (2021-2026) Table 164. Global EGFR-TKI Revenue Market Share by Application (2027-2032) Table 165. Global EGFR-TKI Price by Application (2021-2026) & (US$/Unit) Table 166. Global EGFR-TKI Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. EGFR-TKI Distributors List Table 170. EGFR-TKI Customers List Table 171. EGFR-TKI Industry Trends Table 172. EGFR-TKI Industry Drivers Table 173. EGFR-TKI Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. EGFR-TKI Product Image Figure 5. Global EGFR-TKI Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global EGFR-TKI Market Size (2021-2032) & (US$ Million) Figure 7. Global EGFR-TKI Sales (2021-2032) & (K Units) Figure 8. Global EGFR-TKI Average Price (US$/Unit) & (2021-2032) Figure 9. Afatinib Product Image Figure 10. Aumolertinib Product Image Figure 11. Icotinib Product Image Figure 12. Osimertinib Product Image Figure 13. Dacomitinib Product Image Figure 14. Erlotinib Product Image Figure 15. Furmonertinib Product Image Figure 16. Gefitinib Product Image Figure 17. Lazertinib Product Image Figure 18. Other Product Image Figure 19. Segment by Application Product Image Figure 20. Hospital and Clinic Product Image Figure 21. Retail Pharmacies Product Image Figure 22. Other Product Image Figure 23. Global EGFR-TKI Revenue Share by Manufacturers in 2025 Figure 24. Global Manufacturers of EGFR-TKI, Manufacturing Sites & Headquarters Figure 25. Global Top 5 and 10 EGFR-TKI Players Market Share by Revenue in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global EGFR-TKI Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 28. Global EGFR-TKI Sales by Region in 2025 Figure 29. Global EGFR-TKI Revenue by Region in 2025 Figure 30. North America EGFR-TKI Market Size by Country in 2025 Figure 31. North America EGFR-TKI Sales Market Share by Country (2021-2032) Figure 32. North America EGFR-TKI Revenue Market Share by Country (2021-2032) Figure 33. United States EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Mexico EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Europe EGFR-TKI Market Size by Country in 2025 Figure 37. Europe EGFR-TKI Sales Market Share by Country (2021-2032) Figure 38. Europe EGFR-TKI Revenue Market Share by Country (2021-2032) Figure 39. Germany EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. France EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. U.K. EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Italy EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Russia EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Spain EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Netherlands EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Switzerland EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Sweden EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Poland EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Asia Pacific EGFR-TKI Market Size by Country in 2025 Figure 50. Asia Pacific EGFR-TKI Sales Market Share by Country (2021-2032) Figure 51. Asia Pacific EGFR-TKI Revenue Market Share by Country (2021-2032) Figure 52. China EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Japan EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South Korea EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. India EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Australia EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Taiwan EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Southeast Asia EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Southeast Asia EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South America EGFR-TKI Market Size by Country in 2025 Figure 61. South America EGFR-TKI Sales Market Share by Country (2021-2032) Figure 62. South America EGFR-TKI Revenue Market Share by Country (2021-2032) Figure 63. Brazil EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Argentina EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Chile EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Middle East and Africa EGFR-TKI Market Size by Country in 2025 Figure 67. Middle East and Africa EGFR-TKI Sales Market Share by Country (2021-2032) Figure 68. Middle East and Africa EGFR-TKI Revenue Market Share by Country (2021-2032) Figure 69. Egypt EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. South Africa EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Israel EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 72. Türkiye EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 73. GCC Countries EGFR-TKI Revenue Growth Rate (2021-2032) & (US$ Million) Figure 74. Global EGFR-TKI Sales Market Share by Type (2021-2032) Figure 75. Global EGFR-TKI Revenue Market Share by Type (2021-2032) Figure 76. Global EGFR-TKI Price (US$/Unit) by Type (2021-2032) Figure 77. Global EGFR-TKI Sales Market Share by Application (2021-2032) Figure 78. Global EGFR-TKI Revenue Market Share by Application (2021-2032) Figure 79. Global EGFR-TKI Price (US$/Unit) by Application (2021-2032) Figure 80. EGFR-TKI Value Chain Figure 81. EGFR-TKI Production Mode & Process Figure 82. Direct Comparison with Distribution Share Figure 83. Distributors Profiles Figure 84. EGFR-TKI Industry Opportunities and Challenges

Scope & coverage.

Types
  • Afatinib
  • Aumolertinib
  • Icotinib
  • Osimertinib
  • Dacomitinib
  • Erlotinib
  • Furmonertinib
  • Gefitinib
  • Lazertinib
  • Other
Applications
  • Segment by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • ArriVent Biopharma
  • AstraZeneca
  • Beacon Pharma
  • Boehringer Ingelheim Pharmaceuticals
  • Cipla
  • Drug International
  • Glenmark Pharmaceuticals
  • Hanmi Pharmaceutical
  • Johnson & Johnson
  • Mylan
  • Pfizer
  • Roche
  • Teva
  • Yuhan Corporation
  • Betta Pharma
  • Chengdu Brilliant Pharmaceuticals
  • Hansoh Pharma
  • Shanghai Allist Pharmaceuticals
  • Wanbang Biopharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global EGFR-TKI Market Size (2021-2032)
  4. 2.2.2 Global EGFR-TKI Sales (2021-2032)
  5. 2.2.3 Global EGFR-TKI Market Average Price (2021-2032)
  6. 2.3 EGFR-TKI by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Afatinib
  9. 2.3.3 Aumolertinib
  10. 2.3.4 Icotinib
  11. 2.3.5 Osimertinib
  12. 2.3.6 Dacomitinib
  13. 2.3.7 Erlotinib
  14. 2.3.8 Furmonertinib
  15. 2.3.9 Gefitinib
  16. 2.3.10 Lazertinib
  17. 2.3.11 Other
  18. 2.4 EGFR-TKI by Application
  19. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  20. 2.4.2 Segment by Application
  21. 2.4.3 Hospital and Clinic
  22. 2.4.4 Retail Pharmacies
  23. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global EGFR-TKI Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global EGFR-TKI Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global EGFR-TKI Revenue of Manufacturers (2021-2026)
  4. 3.4 Global EGFR-TKI Average Price by Manufacturers (2021-2026)
  5. 3.5 Global EGFR-TKI Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of EGFR-TKI, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of EGFR-TKI, Product Type & Application
  8. 3.8 Global Manufacturers of EGFR-TKI, Established Date
  9. 3.9 Global EGFR-TKI Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 ArriVent Biopharma
  2. 4.1.1 ArriVent Biopharma Company Information
  3. 4.1.2 ArriVent Biopharma Business Overview
  4. 4.1.3 ArriVent Biopharma EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 ArriVent Biopharma EGFR-TKI Product Portfolio
  6. 4.1.5 ArriVent Biopharma Recent Developments
  7. 4.2 AstraZeneca
  8. 4.2.1 AstraZeneca Company Information
  9. 4.2.2 AstraZeneca Business Overview
  10. 4.2.3 AstraZeneca EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 AstraZeneca EGFR-TKI Product Portfolio
  12. 4.2.5 AstraZeneca Recent Developments
  13. 4.3 Beacon Pharma
  14. 4.3.1 Beacon Pharma Company Information
  15. 4.3.2 Beacon Pharma Business Overview
  16. 4.3.3 Beacon Pharma EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Beacon Pharma EGFR-TKI Product Portfolio
  18. 4.3.5 Beacon Pharma Recent Developments
  19. 4.4 Boehringer Ingelheim Pharmaceuticals
  20. 4.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
  21. 4.4.2 Boehringer Ingelheim Pharmaceuticals Business Overview
  22. 4.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolio
  24. 4.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
  25. 4.5 Cipla
  26. 4.5.1 Cipla Company Information
  27. 4.5.2 Cipla Business Overview
  28. 4.5.3 Cipla EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Cipla EGFR-TKI Product Portfolio
  30. 4.5.5 Cipla Recent Developments
  31. 4.6 Drug International
  32. 4.6.1 Drug International Company Information
  33. 4.6.2 Drug International Business Overview
  34. 4.6.3 Drug International EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Drug International EGFR-TKI Product Portfolio
  36. 4.6.5 Drug International Recent Developments
  37. 4.7 Glenmark Pharmaceuticals
  38. 4.7.1 Glenmark Pharmaceuticals Company Information
  39. 4.7.2 Glenmark Pharmaceuticals Business Overview
  40. 4.7.3 Glenmark Pharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Glenmark Pharmaceuticals EGFR-TKI Product Portfolio
  42. 4.7.5 Glenmark Pharmaceuticals Recent Developments
  43. 4.8 Hanmi Pharmaceutical
  44. 4.8.1 Hanmi Pharmaceutical Company Information
  45. 4.8.2 Hanmi Pharmaceutical Business Overview
  46. 4.8.3 Hanmi Pharmaceutical EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hanmi Pharmaceutical EGFR-TKI Product Portfolio
  48. 4.8.5 Hanmi Pharmaceutical Recent Developments
  49. 4.9 Johnson & Johnson
  50. 4.9.1 Johnson & Johnson Company Information
  51. 4.9.2 Johnson & Johnson Business Overview
  52. 4.9.3 Johnson & Johnson EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Johnson & Johnson EGFR-TKI Product Portfolio
  54. 4.9.5 Johnson & Johnson Recent Developments
  55. 4.10 Mylan
  56. 4.10.1 Mylan Company Information
  57. 4.10.2 Mylan Business Overview
  58. 4.10.3 Mylan EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Mylan EGFR-TKI Product Portfolio
  60. 4.10.5 Mylan Recent Developments
  61. 4.11 Pfizer
  62. 4.11.1 Pfizer Company Information
  63. 4.11.2 Pfizer Business Overview
  64. 4.11.3 Pfizer EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Pfizer EGFR-TKI Product Portfolio
  66. 4.11.5 Pfizer Recent Developments
  67. 4.12 Roche
  68. 4.12.1 Roche Company Information
  69. 4.12.2 Roche Business Overview
  70. 4.12.3 Roche EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Roche EGFR-TKI Product Portfolio
  72. 4.12.5 Roche Recent Developments
  73. 4.13 Teva
  74. 4.13.1 Teva Company Information
  75. 4.13.2 Teva Business Overview
  76. 4.13.3 Teva EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Teva EGFR-TKI Product Portfolio
  78. 4.13.5 Teva Recent Developments
  79. 4.14 Yuhan Corporation
  80. 4.14.1 Yuhan Corporation Company Information
  81. 4.14.2 Yuhan Corporation Business Overview
  82. 4.14.3 Yuhan Corporation EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Yuhan Corporation EGFR-TKI Product Portfolio
  84. 4.14.5 Yuhan Corporation Recent Developments
  85. 4.15 Betta Pharma
  86. 4.15.1 Betta Pharma Company Information
  87. 4.15.2 Betta Pharma Business Overview
  88. 4.15.3 Betta Pharma EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Betta Pharma EGFR-TKI Product Portfolio
  90. 4.15.5 Betta Pharma Recent Developments
  91. 4.16 Chengdu Brilliant Pharmaceuticals
  92. 4.16.1 Chengdu Brilliant Pharmaceuticals Company Information
  93. 4.16.2 Chengdu Brilliant Pharmaceuticals Business Overview
  94. 4.16.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolio
  96. 4.16.5 Chengdu Brilliant Pharmaceuticals Recent Developments
  97. 4.17 Hansoh Pharma
  98. 4.17.1 Hansoh Pharma Company Information
  99. 4.17.2 Hansoh Pharma Business Overview
  100. 4.17.3 Hansoh Pharma EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hansoh Pharma EGFR-TKI Product Portfolio
  102. 4.17.5 Hansoh Pharma Recent Developments
  103. 4.18 Shanghai Allist Pharmaceuticals
  104. 4.18.1 Shanghai Allist Pharmaceuticals Company Information
  105. 4.18.2 Shanghai Allist Pharmaceuticals Business Overview
  106. 4.18.3 Shanghai Allist Pharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolio
  108. 4.18.5 Shanghai Allist Pharmaceuticals Recent Developments
  109. 4.19 Wanbang Biopharmaceuticals
  110. 4.19.1 Wanbang Biopharmaceuticals Company Information
  111. 4.19.2 Wanbang Biopharmaceuticals Business Overview
  112. 4.19.3 Wanbang Biopharmaceuticals EGFR-TKI Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Wanbang Biopharmaceuticals EGFR-TKI Product Portfolio
  114. 4.19.5 Wanbang Biopharmaceuticals Recent Developments
5 Global EGFR-TKI Market Scenario by Region
  1. 5.1 Global EGFR-TKI Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global EGFR-TKI Sales by Region: 2021-2032
  3. 5.2.1 Global EGFR-TKI Sales by Region: 2021-2026
  4. 5.2.2 Global EGFR-TKI Sales by Region: 2027-2032
  5. 5.3 Global EGFR-TKI Revenue by Region: 2021-2032
  6. 5.3.1 Global EGFR-TKI Revenue by Region: 2021-2026
  7. 5.3.2 Global EGFR-TKI Revenue by Region: 2027-2032
  8. 5.4 North America EGFR-TKI Market Facts & Figures by Country
  9. 5.4.1 North America EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America EGFR-TKI Sales by Country (2021-2032)
  11. 5.4.3 North America EGFR-TKI Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe EGFR-TKI Market Facts & Figures by Country
  16. 5.5.1 Europe EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe EGFR-TKI Sales by Country (2021-2032)
  18. 5.5.3 Europe EGFR-TKI Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific EGFR-TKI Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific EGFR-TKI Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific EGFR-TKI Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America EGFR-TKI Market Facts & Figures by Country
  41. 5.7.1 South America EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America EGFR-TKI Sales by Country (2021-2032)
  43. 5.7.3 South America EGFR-TKI Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa EGFR-TKI Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa EGFR-TKI Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa EGFR-TKI Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa EGFR-TKI Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global EGFR-TKI Sales by Type (2021-2032)
  2. 6.1.1 Global EGFR-TKI Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global EGFR-TKI Sales Market Share by Type (2021-2032)
  4. 6.2 Global EGFR-TKI Revenue by Type (2021-2032)
  5. 6.2.1 Global EGFR-TKI Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global EGFR-TKI Revenue Market Share by Type (2021-2032)
  7. 6.3 Global EGFR-TKI Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global EGFR-TKI Sales by Application (2021-2032)
  2. 7.1.1 Global EGFR-TKI Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global EGFR-TKI Sales Market Share by Application (2021-2032)
  4. 7.2 Global EGFR-TKI Revenue by Application (2021-2032)
  5. 7.2.1 Global EGFR-TKI Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global EGFR-TKI Revenue Market Share by Application (2021-2032)
  7. 7.3 Global EGFR-TKI Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 EGFR-TKI Value Chain Analysis
  2. 8.1.1 EGFR-TKI Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 EGFR-TKI Production Mode & Process
  5. 8.2 EGFR-TKI Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 EGFR-TKI Distributors
  8. 8.2.3 EGFR-TKI Customers
9 Global EGFR-TKI Analyzing Market Dynamics
  1. 9.1 EGFR-TKI Industry Trends
  2. 9.2 EGFR-TKI Industry Drivers
  3. 9.3 EGFR-TKI Industry Opportunities and Challenges
  4. 9.4 EGFR-TKI Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst